Simultaneous elevation of the levels of circulating monocyte chemoattractant protein-1 and tissue factor in acute coronary syndromes.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Japanese circulation journal

• Publication date

  1998-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1253/JCJ.62.710PMID 9766714
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of plasma tissue factor levels in unstable and stable angina pectoris.

  1998cited by this paper
• Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes.

  1996cited by this paper
• Increased monocyte tissue factor expression in coronary disease.

  1995cited by this paper
• Monocyte chemoattractant protein-1 in idiopathic pulmonary fibrosis and other interstitial lung diseases.

  1994cited by this paper
• Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody.

  1993cited by this paper
• The pathogenesis of coronary artery disease and the acute coronary syndromes (2).

  1992cited by this paper
• The pathogenesis of coronary artery disease and the acute coronary syndromes (1).

  1992cited by this paper
• Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis.

  1992cited by this paper
• Human monocyte chemoattractant protein-1 (MCP-1).

  1990cited by this paper
• Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque.

  1989cited by this paper
• Tissue factor and hemostasis.

  1988cited by this paper

• Electrochemiluminescence ratio sensor for detecting MCP-1 based on s-PdNS

  2024cites this paper
• Effects of Interleukin-17A on the Early Stages of Arterial Thrombosis in Mice

  2022cites this paper
• Usefulness of MCP-1 Chemokine in the Monitoring of Patients with Coronary Artery Disease Subjected to Intensive Dietary Intervention: A Pilot Study

  2021cites this paper
• Targeted anti-inflammatory therapy is a new insight for reducing cardiovascular events: A review from physiology to the clinic.

  2020cites this paper
• A sensitive sandwich-type immunosensor for the detection of MCP-1 based on a rGO-TEPA-Thi-Au nanocomposite and novel RuPdPt trimetallic nanoalloy particles.

  2019cites this paper
• Factors Associated with RANTES Concentration in Cardiovascular Disease Patients

  2019cites this paper
• Cytokines and MicroRNA in Coronary Artery Disease.

  2017cites this paper
• Association of monocyte count on admission with angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.

  2016cites this paper
• Ultrasensitive electrochemical immunosensor based on orderly oriented conductive wires for the detection of human monocyte chemotactic protein-1 in serum.

  2015cites this paper
• Serum Levels of Monocyte Chemoattractant Protein-1 and All-Cause and Cardiovascular Mortality among Patients with Coronary Artery Disease

  2015influential citation
• coronary artery disease Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for

  2013cites this paper
• In search for novel biomarkers of acute coronary syndrome.

  2012cites this paper
• Ethnic differences in endothelial function and monocyte subsets in heart failure

  2012cites this paper
• Traditional and Novel Risk Factors in Atherothrombosis

  2012cites this paper
• [The relation of serum monocyte chemoattractant protein-1 level with coronary atherosclerotic burden and collateral degree in stable coronary artery disease].

  2011cites this paper
• Serum monosit kemoatraktan protein-1 düzeyinin kararli koroner arter hastaliğinda koroner aterosklerotik yük ve kolateral derecesi ile ilişkisi The relation of serum monocyte chemoattractant protein-1 level with coronary atherosclerotic burden and collateral degree in stable coronary artery disease

  2011cites this paper
• High White Blood Cell Count and Low Estimated Glomerular Filtration Rate Are Independently Associated With Serum Level of Monocyte Chemoattractant Protein‐1 in a General Population

  2011cites this paper
• Circulating thrombotic and haemostatic components in patients with coronary artery disease

  2010cites this paper
• Serum profiles of monocyte chemoattractant protein-1 as a biomarker for patients recovering from myocardial infarction

  2010cites this paper
• Novel systemic cardiovascular disease biomarkers.

  2010cites this paper
• Effects of ramipril on serum monocyte chemoattractant protein 1, interleukin-18, and interleukin-10 in elderly patients with acute coronary syndrome

  2010cites this paper
• Monocyte chemoattractant protein-1-2518 G/A polymorphism, plasma levels, and premature stable coronary artery disease

  2009cites this paper
• Monocyte chemoattractant protein-1/CCL2 as a biomarker in acute coronary syndromes

  2009cites this paper
• Correlation between inflammatory markers and the progression of atherosclerosis in patients with coronary artery disease

  2008cites this paper
• Role of Chemokines and Chemokine Receptors in Diseases of Ageing

  2007cites this paper
• Serum markers of vascular inflammation in dyslipemia.

  2006cites this paper
• Adipokine expression and secretion: a target for pharmacologic treatment

  2006cites this paper
• [Markers of inflammation--monocyte chemoattractant protein-1 (MCP-1) and C-reactive protein--in blood of patients with unstable angina pectoris and stable effort angina].

  2006cites this paper
• Adipopharmacology of Disease ADIPOKINE EXPRESSION AND SECRETION : A TARGET FOR PHARMACOLOGIC TREATMENT

  2006cites this paper
• Chemoattractants as causative agents, biomarkers and therapeutic targets in vascular pathology

  2006cites this paper
• Strenuous physical exercise induces monocyte chemoattractant protein-1 release in patients with coronary artery disease

  2005cites this paper
• Elevated plasma osteopontin levels were associated with osteopontin expression of CD4+ T cells in patients with unstable angina.

  2005cites this paper
• Elevated monocyte chemoattractant protein-1 serum levels in patients at risk for coronary artery disease.

  2005cites this paper
• Monocyte chemoattractant protein‐1 and recurrent cardiovascular events in patients with stable coronary heart disease

  2005cites this paper
• Markers of inflammation and their clinical significance.

  2005cites this paper
• Myocardial Ischemia Induces Interleukin-6 and Tissue Factor Production in Patients With Coronary Artery Disease: A Dobutamine Stress Echocardiography Study

  2005cites this paper
• Significance of the level of monocyte chemoattractant protein-1 in human atherosclerosis.

  2004cites this paper
• The Clinical Significance of Serum-Hydroxyproline in Acute Coronary Syndrome

  2004cites this paper
• Plasma concentrations of monocyte chemoattractant protein 1 (MCP-1) and neopterin in the coronary circulation of patients with coronary artery disease.

  2004cites this paper
• Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis.

  2004cites this paper
• Outcomes in Patients With Acute Coronary Syndromes Association Between Plasma Levels of Monocyte Chemoattractant Protein-1 and

  2003cites this paper
• Circulating markers of inflammation and atherosclerosis.

  2003cites this paper
• Association Between Plasma Levels of Monocyte Chemoattractant Protein-1 and Long-Term Clinical Outcomes in Patients With Acute Coronary Syndromes

  2003cites this paper
• Tissue Factor in Acute Coronary Syndromes

  2003cites this paper
• Tissue factor – a therapeutic target for thrombotic disorders

  2002cites this paper
• Increased expression of monocyte chemoattractant protein-1 in atherectomy specimens from patients with restenosis after percutaneous transluminal coronary angioplasty.

  2002cites this paper
• Chlamydia pneumoniae and atherosclerosis -- what we know and what we don't.

  2002cites this paper
• Statins and inflammatory markers

  2002cites this paper
• Increased levels of monocyte-related cytokines in patients with unstable angina.

  2002cites this paper
• Monocyte chemoattractant protein‐1 and coronary artery disease

  2002cites this paper
• Atorvastatin Reduces Expression of the CCR2 and MAC-1 Receptors on Monocytes, and Plasma Levels of Monocyte Chemoattractant Protein-1 and C-Reactive Protein, in Patients with Coronary Heart Disease

  2002cites this paper
• Leukocytes and Coronary Artery Disease: Experimental and Clinical Studies

  2002cites this paper
• Leukocytes and Coronary Artery Disease

  2002cites this paper
• Plasma monocyte chemoattractant protein-1 antigen levels and the risk of restenosis after coronary stent implantation.

  2001cites this paper
• Increased circulating monocyte activation in patients with unstable coronary syndromes.

  2001cites this paper
• Blood cell activation, coagulation, and inflammation in men and women with coronary artery disease.

  2001cites this paper
• Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease.

  2001cites this paper
• Activation of CD14 on circulating monocytes in patients with acute coronary syndrome.

  2001cites this paper
• Systemic response of peripheral blood leukocytes and their phagocytic activity during acute myocardial infarction.

  2001cites this paper
• Effect of trapidil on effector functions of monocytes related to atherosclerotic plaque.

  2001cites this paper
• Increased plasma antigen levels of monocyte chemoattractant protein-1 in patients with restenosis after percutaneous transluminal coronary angioplasty.

  2000cites this paper
• Plasma Inflammatory Markers and T-Lymphocytes Are Activated in Angina Pectoris

  2000cites this paper
• Polymorphisms in the 5' regulatory region of the tissue factor gene and the risk of myocardial infarction and venous thromboembolism: the ECTIM and PATHROS studies. Etude Cas-Témoins de l'Infarctus du Myocarde. Paris Thrombosis case-control Study.

  2000cites this paper
• Correlation between monocyte and T-lymphocyte activation markers in patients with acute coronary syndrome.

  2000cites this paper
• Angiotensin-converting enzyme inhibition reduces monocyte chemoattractant protein-1 and tissue factor levels in patients with myocardial infarction.

  1999cites this paper